Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s diseaseDarian Williams, Yu Chen|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in <i>GBA1</i> isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonismChase Chen, Yu Chen|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0